Search

Your search keyword '"De Blay, F"' showing total 103 results

Search Constraints

Start Over You searched for: Author "De Blay, F" Remove constraint Author: "De Blay, F" Database OAIster Remove constraint Database: OAIster
103 results on '"De Blay, F"'

Search Results

1. Rhinitis associated with asthma is distinct from rhinitis alone:The ARIA-MeDALL hypothesis

2. Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app

3. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis

4. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis

5. A European-Japanese study on peach allergy: IgE to Pru p 7 associates with severity

6. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis

7. Rhinitis associated with asthma is distinct from rhinitis alone:The ARIA-MeDALL hypothesis

8. Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app

9. Sputum Inflammatory Patterns are Associated with Distinct Clinical Characteristics in Subjects with Occupational Asthma Independently from the Causal Agent.

10. Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app.

11. Phénotypage de l’asthme professionnel par la réalisation d’expectoration induite après test d’exposition spécifique

12. Walnut Allergy across Europe: Distribution of Allergen Sensitization Patterns and Prediction of Severity

13. Biological treatments in allergy: Prescribing patterns and management of hypersensitivity reactions

14. Biological treatments in allergy: Prescribing patterns and management of hypersensitivity reactions

15. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018) : Change management in allergic rhinitis and asthma multimorbidity using mobile technology

16. Adherence to treatment in allergic rhinitis using mobile technology : The MASK Study

17. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

18. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

19. Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study

20. Adherence to treatment in allergic rhinitis using mobile technology : The MASK Study

21. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

22. Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study

23. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

24. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

25. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

26. Component-resolved diagnosis and beyond : Multivariable regression models to predict severity of hazelnut allergy

27. Are high- and low-molecular-weight sensitizing agents associated with different clinical phenotypes of occupational asthma?

28. Component-resolved diagnosis and beyond : Multivariable regression models to predict severity of hazelnut allergy

29. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)

30. Component-resolved diagnosis and beyond : Multivariable regression models to predict severity of hazelnut allergy

31. Component-resolved diagnosis and beyond: Multivariable regression models to predict severity of hazelnut allergy

32. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)

33. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

34. Erratum to : Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

35. Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

36. Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5).

37. Abstracts from the Food Allergy and Anaphylaxis Meeting 2016

38. Erratum to : Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

39. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) (vol 6, 29, 2016)

40. Allergen exposure chambers: harmonizing current concepts and projecting the needs for the future - an EAACI Position Paper

41. Erratum to : Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

42. Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

43. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) (vol 6, 29, 2016)

44. Allergen exposure chambers: harmonizing current concepts and projecting the needs for the future - an EAACI Position Paper

45. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

46. Allergy immunotherapy across the life cycle to promote active and healthy ageing : from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project

47. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3 Area 5)

48. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

49. Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement

50. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3

Catalog

Books, media, physical & digital resources